Whole Body Curcumizer
Goals
$24.47 $0.81 per serving
Product analysis
Whole Body Curcumizer combines ingredients with possible links to joint comfort, skin support and heart-related measurements. Several benefits depend on specific preparations that are not established for this mixture, making the expected effects uncertain.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality21
Most listed ingredient forms are unspecified, leaving their quality difficult to compare. The different DHA declarations should not be combined into a single assumed amount.
Ingredient Transparency63
Most amounts are identified, but one entry lacks an amount and most forms are unspecified. Some mixture details are clear while others remain uncertain, leaving the contents only partly described.
Value For Money72
The declared DHA content offers favorable value. Value for the boswellic-acid content remains uncertain, so that conclusion does not extend to every part of the formula.
Customer Satisfaction78
Customer ratings are very positive across several hundred reviews. That supports a picture of satisfaction without establishing the proposed health effects.
Product Focus63
Possible benefits concern joint comfort, skin support and selected heart-related measurements, with substantial uncertainty about the preparations. The omega-3 content does not establish a general increase in calorie burning.
- Format
Softgel - Container
- 60 Softgel(s)
- Per serving
- $0.81
- Customer rating
- 4.8 · 387 ratings
Goals
Impact
High effect
Fish Oil · 1946 mgAstaxanthin · 2 mgBoswellia · 125 mgCurcumin · 60 mg
DHA contributes to fatty-acid mediators, with omega-3 biomarker findings that do not establish routine clinical benefit. Astaxanthin has a small CRP signal at 2 mg daily in young women, without established clinical improvement or a consistent larger-amount effect. Boswellia has preparation-specific knee osteoarthritis symptom findings, but this material is not identified as a trial preparation. The small curcumin amount is excluded.
How this product is rated for Inflammation
Ingredient fit56
DHA, astaxanthin and Boswellia provide amount-based contributions within a broader formula; curcumin is excluded.
Goal fit
DHA, astaxanthin and Boswellia provide amount-based contributions within a broader formula; curcumin is excluded.
Dose adequacy
Included amounts receive partial overall exposure recognition, with none assigned from generic fish-oil mass.
Pathways61
Fatty-acid mediators and COX/LOX pathways lead, with smaller gene-signalling and oxidative-stress findings.
Depth
Fatty-acid mediators narrowly provide the strongest coverage.
Breadth
Fatty-acid mediators and COX/LOX pathways meet the coverage threshold.
Evidence74
Astaxanthin leads the evidence finding; Boswellia lacks a verified studied preparation.
Evidence strength
Astaxanthin leads the evidence comparison, with a small biomarker signal rather than established clinical benefit.
Studied preparation
DHA and astaxanthin meet the comparison; unidentified Boswellia cannot inherit 5-Loxin or Aflapin trial identity.
Formulation logic100
Recognized ingredients have no missing required partner or listed conflict; their amount findings are described separately.
Partner coverage
No credited ingredient lacks a required partner.
Conflicts
No listed ingredient conflict was found.
Effective doses
All three included ingredients reach the minimum exposure threshold; excluded curcumin is outside this check.
Impact
High effect
Fish Oil · 1946 mgAstaxanthin · 2 mg
Declared DHA provides a triglyceride-related contribution, but findings from concentrated DHA studies do not establish cardiovascular-event prevention. Astaxanthin has limited support for triglyceride and HDL changes in mild hyperlipidemia; its 2 mg serving is below the studied exposures described. Generic turmeric or curcumin cannot inherit the vascular findings for Longvida, and the grape-seed declaration does not establish the exact studied preparation or amount.
How this product is rated for Cardiovascular Support
Ingredient fit54
DHA and astaxanthin contribute; curcumin and unresolved grape-seed details limit the formula's relevance. Amounts contribute unevenly, with some smaller or unresolved exposures limiting the saved amount finding.
Goal fit
DHA and astaxanthin contribute; curcumin and unresolved grape-seed details limit the formula's relevance.
Dose adequacy
Amounts contribute unevenly, with some smaller or unresolved exposures limiting the saved amount finding.
Pathways60
The strongest saved contribution concerns triglyceride metabolism. The main supported area is triglyceride metabolism, so coverage remains narrow.
Depth
The strongest saved contribution concerns triglyceride metabolism.
Breadth
The main supported area is triglyceride metabolism, so coverage remains narrow.
Evidence83
DHA leads the saved evidence finding; the astaxanthin evidence is small and marker-specific.
Evidence strength
DHA leads the saved evidence finding; the astaxanthin evidence is small and marker-specific.
Studied preparation
The saved finding recognizes the relevant preparation declarations, without establishing superiority over other forms.
Formulation logic92
DHA and astaxanthin meet the saved minimum amount criterion; unresolved grape-seed exposure does not. No required partner is missing and no listed conflict was triggered.
Partner coverage
The credited ingredients can contribute alone or have the required partner present.
Conflicts
No listed ingredient conflict was triggered by the supplied facts.
Effective doses
DHA and astaxanthin meet the saved minimum amount criterion; unresolved grape-seed exposure does not.
Impact
Moderate effect
Omega-3 · 1000 mgBoswellia · 125 mgCurcumin · 60 mg
DHA, boswellia and astaxanthin relate mainly to inflammation-related joint support. Their evidence varies by preparation, while the 60 mg curcumin amount makes a limited contribution in the saved assessment. Boswellic-acid marker amounts are part of the botanical description, rather than an additional independent ingredient contribution.
How this product is rated for Joint Health
Ingredient fit58
Joint-related ingredients sit within a formula serving broader purposes. The assessed quantities provide a partial match to the saved benchmarks.
Goal fit
Joint-related ingredients sit within a formula serving broader purposes.
Dose adequacy
The assessed quantities provide a partial match to the saved benchmarks.
Pathways52
The main recorded contribution relates to inflammation and joint comfort. Cartilage-related support forms a smaller contribution. One main mechanism meets the saved coverage benchmark, so support is relatively jointed.
Depth
The main recorded contribution relates to inflammation and joint comfort. Cartilage-related support forms a smaller contribution.
Breadth
One main mechanism meets the saved coverage benchmark, so support is relatively jointed.
Evidence61
Omega-3 provides the strongest evidence contribution among the assessed ingredients. Only part of the qualifying contribution matches studied preparations; boswellia does not.
Evidence strength
Omega-3 provides the strongest evidence contribution among the assessed ingredients.
Studied preparation
Only part of the qualifying contribution matches studied preparations; boswellia does not.
Formulation logic100
The assessed ingredients can contribute independently or have their required partners. No ingredient conflict was flagged by the saved checks.
Partner coverage
The assessed ingredients can contribute independently or have their required partners.
Conflicts
No ingredient conflict was flagged by the saved checks.
Effective doses
All counted ingredients meet the saved minimum amount threshold.
Impact
Moderate effect
Astaxanthin · 2 mgOmega-3 · 1000 mg
Omega-3 provides the main skin-barrier contribution in the saved findings. Evidence for routine benefits depends on fatty-acid composition and preparation.
Astaxanthin at 2 mg adds a smaller antioxidant contribution. Small oral trials suggest support for selected UV-response and moisture measures, but this amount is below the supplied trial exposures.
How this product is rated for Skin Health
Ingredient fit47
The relevant skin ingredients sit alongside ingredients serving other goals. The counted amounts provide partial overall dose support.
Goal fit
The relevant skin ingredients sit alongside ingredients serving other goals.
Dose adequacy
The counted amounts provide partial overall dose support.
Pathways50
Skin-barrier lipids are the main contribution, with a smaller antioxidant contribution.
Depth
Skin-barrier lipids are the main contribution, with a smaller antioxidant contribution.
Breadth
One skin aspect has substantial coverage, while support across other aspects remains limited.
Evidence87
Astaxanthin provides the strongest evidence contribution in the saved findings, with the preparation and nutritional context affecting applicability. The counted ingredients match preparations represented in the supplied evidence.
Evidence strength
Astaxanthin provides the strongest evidence contribution in the saved findings, with the preparation and nutritional context affecting applicability.
Studied preparation
The counted ingredients match preparations represented in the supplied evidence.
Formulation logic100
No required partner is missing and no assessed conflict was identified. All counted ingredients pass the saved minimum amount check, although their support differs.
Partner coverage
No required supporting partner is missing for the counted ingredients.
Conflicts
No assessed ingredient conflict was identified in the supplied findings.
Effective doses
All counted ingredients pass the saved minimum amount check, although their support differs.
Impact
Moderate effect
Omega-3 · 1000 mgCurcumin · 60 mg
Whether omega-3 raises calorie use in adults generally is unclear. Effects on resting metabolism vary across particular groups, so the declared omega-3 amount does not predict a faster metabolism for everyone. Changes in fat handling or other metabolic markers are separate from burning more calories.
How this product is rated for Metabolism Support
Ingredient fit38
Whether omega-3 raises calorie use in adults generally is unclear.
Goal fit
The ingredient list is focused, though a normal metabolic role differs from increasing calorie use.
Dose adequacy
Omega-3 1000 mg. These are serving amounts compared with ingredient reference ranges, not guaranteed calorie-burning doses.
Pathways18
Whether omega-3 raises calorie use in adults generally is unclear.
Depth
Whether omega-3 raises calorie use in adults generally is unclear.
Breadth
The ingredient roles do not imply broad, direct increases in calorie use.
Evidence89
Normal nutrient function and direct increases in calorie use are different outcomes.
Evidence strength
Normal nutrient function and direct increases in calorie use are different outcomes.
Studied preparation
The ingredient forms are recognized, but that alone does not make their metabolic effects transferable to routine calorie burning.
Formulation logic100
No particular ingredient conflict or missing required partner is identified.
Partner coverage
No missing required partner is identified for the relevant ingredients.
Conflicts
No particular ingredient conflict is identified.
Effective doses
The relevant declared amounts reach portions of their comparison ranges; those ranges are not validated minimum doses for increasing calorie use.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Calories | 20 Calorie(s) | |
Total Fat | 2 Gram(s) | |
Cholesterol | 10 mg | |
pharmaceutical grade Fish Oil concentrate (Anchovy, Mackerel, Sardine) | 1946 mg | |
Omega-3 Fatty Acids | 1000 mg | |
Docosahexaenoic Acid Ethyl Ester | 665 mg | |
Theracurmin Curcumin extract (Turmeric) | 60 mg | |
Boswellia extract | 125 mg | |
Boswellic Acid | 75 mg | |
Ultra Fruit Polyphenol Complex | 100 mg | |
Grape (Polyphenol) | 0 NP | |
Pomegranate (Polyphenol) | 0 NP | |
Strawberry (Polyphenols) | 0 NP | |
Cranberry (Polyphenols) | 0 NP | |
Blueberry (Polyphenols) | 0 NP | |
Raspberry (Polyphenols) | 0 NP | |
Bilberry (Polyphenols) | 0 NP | |
Astaxanthin (Haematococcus pluvialis) | 2 mg |
DHA · 665 mg OverallScore80
Two softgels provide 1,000 mg of DHA in ethyl ester form. The DHA costs about $0.82 per gram, though ethyl esters are generally less readily absorbed than triglycerides.
How this ingredient is rated
Active Ingredient Quality & Bioavailability64
The chemical form is established, and antioxidant protection is recorded. The oil is about 51% omega-3.
DHA Chemical Form & Bioavailability
The DHA is in ethyl ester form, which is generally less readily absorbed than triglycerides.
Oxidation Protection & Stability
A protective antioxidant is recorded in the saved label information.
Oil Concentration & Purity
The recorded 1000 mg of omega-3s makes up about 51% of the 1946 mg of oil per serving.
Dose, Safety & Label Transparency95
A serving supplies 1000 mg of DHA from fish oil.
DHA Absolute Dosage
A serving provides 1000 mg of DHA.
Purity & Heavy Metal Verification
The saved information records a qualifying certification claim; test results were not independently verified.
Ingredient Source Transparency
Fish oil is identified as the source.
Value80
The estimated cost is about $0.82 per gram of DHA.
Price per Gram of DHA
The estimated cost is about $0.82 per gram of DHA.
Curcumin (Turmeric) · 60 mg OverallScore16
A serving lists 60 mg of curcumin extract preparation, but its curcuminoid amount is not established in the saved facts. A whole-product serving costs about $0.82.
How this ingredient is rated
Composition and Label Disclosure30
The 60 mg amount describes the preparation; the amount of active curcuminoids remains unknown.
Curcuminoid Amount Disclosure
An extract is identified, but its curcuminoid amount or concentration is not established in the saved facts.
Composition and Label Disclosure0
The preparation amount is available, but it does not establish how much active curcuminoid it contains.
Preparation and Marker Disclosure
The saved 60 mg preparation amount does not establish an active curcuminoid amount or yield.
Commercial Price and Usability20
A whole-product serving costs about $0.82.
Commercial Price per Labeled Serving
The price is about $0.82 per whole-product serving, not for curcumin alone.
Astaxanthin (Haematococcus pluvialis) · 2 mg OverallScore56
A serving provides 2 mg of astaxanthin from Haematococcus pluvialis algae. At the whole-product price, that works out to about $0.41 per mg of listed astaxanthin.
How this ingredient is rated
Active Ingredient Quality & Bioavailability60
Haematococcus pluvialis algae is the recorded source; the label claim is not independently verified.
Biological Source Quality
Haematococcus pluvialis algae is recorded as the source of the astaxanthin.
Formulation Technology
The saved facts do not record a liposomal or water-dispersible formulation claim.
Branded Ingredient Standard
Haematococcus pluvialis is the named algal source; no branded astaxanthin ingredient is identified in the saved facts.
Dose, Safety & Label Transparency69
The active astaxanthin amount is stated as 2 mg per serving; packaging protection is not established by the saved facts.
Clinical Potency per Serving
The label declares 2 mg of astaxanthin per serving.
Active Astaxanthin Yield Transparency
The astaxanthin amount itself is declared as 2 mg per serving.
Ingredient Stability & Packaging
The saved facts do not establish whether the packaging protects the ingredient from light.
Value20
At the whole-product price, the cost is about $0.41 per mg of listed astaxanthin.
Price per Milligram of Active Astaxanthin
The evaluated whole-product price corresponds to about $0.41 per mg of astaxanthin.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Astaxanthin, a natural antioxidant, lowers cholesterol and markers of cardiovascular risk in individuals with prediabetes and dyslipidaemia.
- Antioxidant Lipid Supplement on Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis.
- Administration of natural astaxanthin increases serum HDL-cholesterol and adiponectin in subjects with mild hyperlipidemia.
- Effects of Astaxanthin Supplementation on Glycemic Control and Lipid Profile in Patients With Prediabetes and Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials.
- Astaxanthin Supplemented with High-Intensity Functional Training Decreases Adipokines Levels and Cardiovascular Risk Factors in Men with Obesity.
- Efficacy and safety of turmeric and curcumin in lowering blood lipid levels in patients with cardiovascular risk factors: a meta-analysis of randomized controlled trials.
- Effects of nanocurcumin supplementation on metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials.
- The Effects of Curcumin on Glycemic Control and Lipid Profiles Among Patients with Metabolic Syndrome and Related Disorders: A Systematic Review and Metaanalysis of Randomized Controlled Trials.
- Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial.
- Curcumin Nanomicelle Improves Lipid Profile, Stress Oxidative Factors and Inflammatory Markers in Patients Undergoing Coronary Elective Angioplasty; A Randomized Clinical Trial.
- Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
- Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes.
- A systematic review of fish-oil supplements for the prevention and treatment of hypertension.
- Effects of fish oil-derived fatty acids on suboptimal cardiovascular health: A multicenter, randomized, double-blind, placebo-controlled trial.
- Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
- The anti-inflammatory and antioxidant effects of astaxanthin as an adjunctive therapy in community-acquired pneumonia: a randomized controlled trial.
- The Role of Astaxanthin as an Antioxidant and Anti-Inflammatory Agent in Human Health: A Systematic Review.
- Astaxanthin ameliorates inflammation, oxidative stress, and reproductive outcomes in endometriosis patients undergoing assisted reproduction: A randomized, triple-blind placebo-controlled clinical trial.
- Astaxanthin Modulates Inflammation in Type 2 Diabetes via Regulation of microRNAs, Lysophosphatidylcholine, and α-Hydroxybutyrate.
- Redox-sensitive miRNAs and Humanin could mediate effects of exercise and astaxanthin on oxidative stress and inflammation in type 2 diabetes.